Nucleotide excision repair is a versatile mechanism to repair a variety of bulky DNA adducts. We developed excision repair sequencing (XR-seq) to study nucleotide excision repair of DNA adducts in humans, mice, Arabidopsis thaliana, yeast and Escherichia coli. In this protocol, the excised oligomers, generated in the nucleotide excision repair reaction, are isolated by cell lysis and fractionation, followed by immunoprecipitation with damage-or repair factor-specific antibodies from the non-chromatin fraction. The single-stranded excised oligomers are ligated to adapters and reimmunoprecipitated with damage-specific antibodies. The DNA damage in the excised oligomers is then reversed by enzymatic or chemical reactions before being converted into a sequencing library by PCR amplification. Alternatively, the excised oligomers containing DNA damage, especially those containing irreversible DNA damage such as benzo[a] pyrene-induced DNA adducts, can be converted to a double-stranded DNA (dsDNA) form by using appropriate translesion DNA synthesis (TLS) polymerases and then can be amplified by PCR. The current genome-wide approaches for studying repair measure the loss of damage signal with time, which limits their resolution. By contrast, an advantage of XR-seq is that the repair signal is directly detected above a background of zero. An XR-seq library using the protocol described here can be obtained in 7-9 d.
Introduction
Nucleotide excision repair is widespread in the three domains of life. It is an important, if not the sole, mechanism for removing bulky DNA adducts from the genome, including the major UV photoproducts (cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone photoproducts ((6-4)PPs)), lesions caused by other environmental mutagens such as benzo[a]pyrene and aflatoxins, and anticancer drugs such as cisplatin and oxaliplatin 1-3 . A defect in nucleotide excision repair greatly exacerbates the lethality and mutagenicity of these damaging agents, and nucleotide excision repair deficiency in humans leads to xeroderma pigmentosum, which is characterized by severe solar sensitivity and early onset of skin cancer 1 .
Nucleotide excision repair is influenced by numerous factors in vivo such as transcription, chromatin states, DNA replication, epigenetic modifications of DNA and histones, binding of regulatory proteins to DNA and other factors [4] [5] [6] . To investigate the effects of these factors on repair, an approach that directly detects repair events with high resolution at a genome-wide level is required. Although multiple high-resolution methods that map DNA damage sites in the entire genome have been developed [7] [8] [9] [10] [11] [12] , these methods indirectly measure nucleotide excision repair by determining the disappearance of damage at the interval of two time points, which limits their sensitivity and specificity. Here, we describe in detail a robust and broadly applicable genome-wide approach, termed XR-seq, to study nucleotide excision repair of bulky DNA adducts in vivo at single-nucleotide resolution. Since the original development of XR-seq in cultured human cells for UV-induced DNA damage 13 , we have successfully adapted the XR-seq method to study repair of different DNAdamaging agents in human cells 10, [14] [15] [16] , mice 17 , A. thaliana 18 , yeast 19 and E. coli 20, 21 .
Thus, XR-seq may be applied to diverse species, tissues and biological systems damaged by various substances to investigate nucleotide excision repair directly and other biological processes-most notably transcription and circadian rhythms-indirectly. These applications may help us to understand basic biological functions in a variety of organisms ranging from E. coli to humans and may help improve the efficacy of therapeutic interventions and create crops with more efficient DNA repair mechanisms to better cope with DNA-damaging environmental stresses.
Development and overview of XR-seq
Early mechanistic studies of nucleotide excision repair showed that dual incisions are made in the damaged DNA strand on both sides of the damage. The product is a damage-containing singlestranded oligomer of defined length (mammals and plants, 26-27 nucleotides (nt) ; budding yeast, 23-24 nt; E. coli, 12-13 nt) 1, 3, 19, [22] [23] [24] . Following the characterization of excision repair proteins and reaction mechanisms 1 , attention focused on the fate of these excised, damage-containing oligomers generated during the repair reaction [25] [26] [27] [28] . Experimentally, a gentle cell lysis approach was used to isolate excision products from mammalian cells and then directly co-immunoprecipitate them with antibodies against basal repair factors 26 . Excision products were found to precipitate with TFIIH and XPG, consistent with the known reaction mechanism 26 . TFIIH, a protein complex with helicase activity, separates the duplex to form a 'repair bubble', and XPG cuts the damaged strand on the 3ʹ side of the damage 3 . The ability to isolate bona fide excision products generated in vivo constitutes the basis for the XR-seq procedure.
In XR-seq, the excised oligomers are isolated, ligated to adapters and sequenced; then the valid sequencing reads are identified and aligned to the genome sequence to create maps of where repair has occurred (Fig. 1) . As originally developed for cultured mammalian cells 13 , gentle lysis is followed by isolation of excision products by TFIIH or XPG immunoprecipitation or immunoprecipitation with damage-specific antibodies, and then by ligation of excision products to 5ʹ and 3ʹ adapters that 
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PROTOCOL are compatible with the Illumina TruSeq small RNA protocol. Ligation products are then immunoprecipitated with DNA damage-specific antibodies (available for CPD-, (6-4)PP-, cisplatin-, and benzo[a]pyrene diol epoxide (BPDE)-damaged DNA). Before the next step, PCR amplification of ligation products, the damage must be reversed or removed. This is accomplished for UV photoproducts by photoreactivation with the appropriate CPD-or (6-4)PP-photolyase. Photolyases bind specifically to either a CPD or a PP adduct in DNA and photo-catalytically repair the photoproduct by direct reversal to the original dipyrimidine 1 . The recombinant photolyases used in XR-seq can be prepared by conventional biochemical methods. Platinum damage is reversed by treatment with sodium cyanide (NaCN) 10 . Samples of the repaired, ligated products and control unrepaired products are subjected to pilot PCR. The purpose is threefold: to demonstrate successful PCR of an appropriate-sized product, to demonstrate that PCR is repair dependent (i.e., photoreactivation or cyanide treatment worked) and to determine the fewest number of PCR cycles needed to generate a library for sequencing in the subsequent preparative-scale PCR reaction. For some lesions that cannot be reversed in vitro such as BPDE adducts, we have developed translesion XR-seq (tXR-seq) by using an appropriate TLS polymerase to bypass the damage and enable subsequent high-fidelity PCR amplification 29 . In the tXR-seq method 29 , the BPDE adduct-containing excision products, immunoprecipitated with anti-BPDE antibody, are subjected to a single round of primer extension by DNA polymerase ĸ, which is able to bypass the damage in an error-free manner. Primer extension by TLS polymerase has also been used to replace the photoreactivation step required in CPD XR-seq. For CPD-containing excision products, DNA polymerase ƞ is used to accurately bypass the CPD in the primer extension reaction 29 . The extension products are amplified to generate a library for next-generation sequencing (NGS).
Modifications to the procedure were also made to apply XR-seq to species for which immunoprecipitation with anti-human repair protein antibodies is not applicable. For XR-seq in E. coli 20 , cell lysis is followed by anti-DNA damage-specific immunoprecipitation. The remaining procedure, including a second damage-specific immunoprecipitation following ligation of excision products to adapters, is the same as in the original procedure. Experiments with yeast 19 and A. thaliana 18 follow this same strategy, with the exception that very harsh methods for cell wall lysis are applied. By contrast, excision products in mice are complexed with TFIIH, and only modest procedural modifications of the original XR-seq protocol are needed to isolate the excised oligomers from various mouse tissues in a form amenable to immunoprecipitation with anti-mammalian TFIIH antibodies.
Advantages and applications of XR-seq
XR-seq is a powerful tool that enables genome-wide analysis of nucleotide excision repair of different DNA-damaging agents in a wide variety of organisms and formats, including cultured cells and entire organisms or tissues. The two-step immunoprecipitation procedure with different antibodies excludes most nonspecific genomic DNA fragments, which reduces the background of XR-seq to nearly zero. During excision repair, the excision products are continually degraded by nucleases, thus the repair map generated at each time point following damage illustrates a snapshot of a dynamic process of ongoing repair. The method indirectly but robustly detects transcription as well.
XR-seq has been applied to explore species-specific and damage-specific characteristics of repair, as well as regulation of repair by chromatin structure and states. The 'chromatin state' of a genomic region can refer to the set of chromatin-associated proteins and histone modifications in that region 30 . The most striking finding is the extent of the effect of transcription on repair. A transcription-coupled repair pathway exists in which RNA polymerase II (RNAP II) blocked by a template strand lesion targets the lesion for rapid repair by the basal repair factors 5 . For lesions such as CPDs and cisplatin-DNA adducts that are poorly repaired by the basal repair factors, this pathway greatly accelerates repair of template strand lesions, whereas the readily recognized PP is rapidly repaired in both strands. Strong strand-specific repair has been observed so far in mouse 17 , A. thaliana 18 , cultured human cells 13 , budding yeast 19 and E. coli 20, 21 genomes, although in the bacterium it is somewhat obscured due to the prevalence of overlapping genes and antisense transcription [31] [32] [33] .
XR-seq has been applied to reveal numerous features of transcription-coupled repair. Analyses of genes from higher organisms have revealed associations between RNAP II density and repair and between transcription level and repair, and have also detected divergent transcription at promoters 13 . These analyses have also shown a strong correspondence between sites of RNAP II pausing (by native elongating transcript sequencing (NET-seq)) and repair, and shown progression of repair, with time, from the transcribed strand to the nontranscribed strand 19 . XR-seq maps have also shown repair to be prioritized by chromatin accessibility. Time course studies showed that, in mammalian cells, there is a bias toward repair of more accessible regions, which is most pronounced at early time points 14, 15 .
Interestingly, studies with A. thaliana plants 18 and mice 17 have demonstrated that repair exhibits circadian rhythmicity owing to the rhythmic control of transcription (and thus transcription-coupled repair) of many genes. In mice, the basal repair also oscillates 34, 35 , with a peak activity just before dusk. This leads to complex patterns of repair in mice, and the startling observation that, in some genes, the transcribed strand is preferentially repaired in the morning whereas the nontranscribed strand is repaired in the evening.
At the molecular level, DNA metabolic processes such as replication and processing of interstrand crosslinks can be studied to examine their effects on the distribution of repair. Also, XR-seq data have been used to examine how repair heterogeneity determines the distribution of mutation frequency in some cancers 12, [36] [37] [38] [39] [40] . These comparisons are possible in well-characterized systems in which genomewide chromatin structure and mutagenesis data are available. In these and in less-well-defined systems, the procedure will be valuable toward defining the basic repair and repair-associated proteins for a given species by the use of appropriate mutant or transgenic cells or organisms. XR-seq can be applied to study a variety of mutagens individually, or to study the consequences of exposure to multiple drugs or toxins, such as in complex environmental mixtures or anticancer therapy regimens, and possible interactions and non-additive effects, and thereby guide the development of drugs and assessments of their toxicity.
Cells exist in various stages of growth and differentiation. In light of the utility of XR-seq as a sensitive probe of gene expression, both gene activity and regions of open chromatin can be probed by XR-seq. The effects of disruption of growth by nutrient deprivation or growth stimulation and different types of stress (altered oxygen availability, pH and temperature) on DNA repair and transcription can be studied by XR-seq. These and other factors, including pathogenic responses and cell-cell interactions, can be investigated using XR-seq to obtain repair and transcription data relevant to normal physiological conditions. At the organismal level, XR-seq studies allow detailed illustrations of circadian rhythmicity in transcription and repair in plants and mice. Embryonic and mature tissues under various conditions are also amenable to the procedure. Practical applications may be found in assessing transcription and repair in normal and diseased tissues during cancer therapy, in addressing issues such as drug resistance and evaluating treatments such as chronotherapy (therapy applied at a specific time of day to maximize the therapeutic index). Other applications may be found in improving the performance of biological systems such as crops.
Limitations
An XR-seq experiment typically yields on the order of 10 million excision product reads per sample. For human and mouse genomes, the coverage that this provides is less than ideal; that is, each individual excision product is unlikely to be represented more than once. There is less constraint with organisms having smaller genomes; several dozen reads or more for each excision site are commonly obtained for E. coli 20, 21 .
XR-seq studies have revealed variations in repair in different regions of the genome. These variations have been attributed to factors that are known to influence repair, such as transcription. Analyses of these data have assumed nearly uniform distribution of damage, and experimental evidence for uniformity is available 15 . However, measurements of damage are perhaps even more impacted by constraints of coverage than are measurements of repair. The relatively low coverage in measurement of both damage and repair has hindered the ability to compare, genome-wide, repair as a function of damage level, and to explore factors relevant to repair, such as sequence context.
Perhaps the most serious limitation of XR-seq is the inability to measure true rates of repair. XRseq can be used to determine relative rates, but because the excised oligomers are concurrently formed and degraded 3 , and rates of degradation in different species are unknown, actual repair rates cannot be calculated.
Degradation of the excision product is also an important factor in determining the amount of specimen needed for XR-seq. The level of degradation varies among species, cell lines and tissues, and thus specimen requirements are determined empirically. At early time points following DNA damage, the repair rate exceeds degradation, and full-length product is most readily available ( Fig. 2a ). However, as repair slows, excision products are available in diminishing amounts 26 . In isolated cases,
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PROTOCOL it has been possible to 'boost' the repair signal. In one set of experiments, E. coli triple exonuclease mutant cells (exoI − , exoVII − , recJ − ) were used to reduce digestion of the repair product. In a separate set of experiments, interestingly, uvrD − E. coli cells gave an exceptionally high yield of full-length product 20 . In these cells, the excision product is protected from nucleases by remaining annealed to the chromosome; the UvrD helicase assists in the release of the excision products from the genome. Unfortunately, eukaryotes have an excision reaction mechanism that is different from the bacterial mechanism. In mammalian repair, the damaged region is melted (in the reaction intermediate, the damage exists in a single-stranded region of a 'repair bubble') before incisions are made, and a comparable protective mechanism does not exist 1 .
The diminishing availability of excision repair product at late time points, when overall repair nears completion, may limit the opportunity to perform XR-seq in some cases. Opportunities may also be limited by the availability of desired biological samples, including clinical specimens.
Chemical mutagens introduce an additional timing issue, although this is not specific to the XR-seq method. UV light is an ideal mutagen in that it is readily delivered in controlled doses, with irradiation taking only seconds to minutes. By contrast, chemicals such as cisplatin and oxaliplatin can take considerably longer between initial dosing and DNA damage, even in cultured cells. Thus, repair begins as damage continues to accumulate. In animals, time is also needed for distribution throughout the body, and drugs such as benzo[a]pyrene require additional time for biotransformation to the ultimate mutagenic form 41 .
Comparison with other methods
The repair field has continually developed novel methods to successfully investigate interesting problems. To date, in vivo methods have commonly measured repair as loss of DNA damage with time following exposure to a mutagen. These in vivo methods have also commonly measured repair at the gene-and/or genome-wide levels, and adduct detection methods have been based on nuclease or chemical sensitivity, or immunoreactivity [7] [8] [9] [10] [11] [12] 24, 34, [42] [43] [44] [45] [46] . A representative and illustrative example of these in vivo methods is the slot blot assay, which measures repair as loss of DNA damage from the entire genome with time 34, 35 . At a given time point, slot blot data reveal what percentage of the total genome has been repaired, whereas XR-seq data reveal where in the genome repair occurred. The same anti-DNA damage antibodies can be used in both methods. Thus, slot blot is valuable because it complements XR-seq. In slot blot, genomic DNA is isolated from control untreated cells and mutagen-treated cells either unrepaired or repaired for various times. An apparatus is used to apply equivalent amounts of each DNA sample to a membrane in uniform-sized 'slots'. The membrane is probed with anti-DNA damage-specific antibodies, and repair is inferred from the loss of the damaged DNA signal with time. This method is applicable to diverse species. For example, it was used to demonstrate overall repair of UV damage in plant cells 24 and to confirm in vitro studies 47 by demonstrating circadian rhythmicity in overall excision repair in mice 35 .
Other related methods use different strategies to measure damage and repair (as loss of damage) in specific genomic fragments or genome-wide. One such strategy uses a UV damage-specific nuclease to digest DNA at damage sites, and then different detection methods are used to measure the damage level. Among these methods, Southern blot can detect the total damage level in a specific region of the genome at low resolution 42 . Three high-resolution methods, ligation-mediated PCR 43, 48, 49 , radiolabeled primer extension of damaged templates 50, 51 and direct end labeling of DNA fragments cleaved at lesions 44, 52 , are able to map DNA damage sites at nucleotide resolution in a specific region. Recently, Excision-seq 8 and CPD-seq 6, 11 have been developed to map damage sites at singlenucleotide resolution in the whole genome. Another strategy uses damage-specific antibodies to enrich damaged fragments, followed by microarray chip detection 7, 9, 45 or high-throughput sequencing 12, 46 to map damage sites genome-wide but at low resolution (approximately several hundred base pairs). To overcome this limitation, Damage-seq 10 utilizes a high-fidelity DNA polymerase, which is blocked by damage, to detect the accurate positions of damage in immunoprecipitationenriched damaged fragments, in order to measure damage at single-nucleotide resolution in the whole genome.
These methods have yielded information about the influences of chromatin structure and transcription on damage formation and repair. However, these methods have inherent limitations in either the fraction of the genome characterized (in the case of studying specific genomic fragments) or the resolution (in the case of genomic DNA fragmentation and microarray detection). The most serious drawback common to all these approaches is that repair is measured indirectly by subtraction, that is, as loss of the damage signal with time. By contrast, with XR-seq, the repair signal is directly detected above a background of zero. This is an important difference, especially at early time points when only a small percentage of the damage has been repaired. Subtraction of two large percentages of damage has very low sensitivity and low resolution, whereas the direct-detection approach of XRseq provides high resolution and sensitivity. Early time points are especially informative because they directly show where and when repair is initially prioritized.
The XR-seq technology is within the range of time (7-9 d) and cost (~$2,000) of other genomics methods used in any modern molecular biology laboratory.
Experimental design
The step-by-step protocol described in the Procedure has been optimized for one XR-seq experiment applicable to different species. We strongly recommend using a control (as explained further below) to monitor the success of Step 20 in the Procedure. For CPD damage, damage reversal and TLS in the tube containing the excised oligomers from step 3 above, and mix well by pipetting at least ten times. 5 Add 1 µl of TdT to the mixture from step 4 above, mix well by pipetting at least ten times and incubate the reaction in a water bath at 37°C for 1 h. 6 Extract the radiolabeled excised oligomers by following the protocol described in Box 2 and dissolve the pellet in 6 µl of loading buffer. 7 Load 6 µl of the samples into a 10% denaturing acrylamide gel. 8 Run the gel at 25-35 W (2,000 V, 35 mA) until the blue dye is 5-8 cm from the bottom. Then run at 60 W until the blue dye is 1-3 cm from the bottom. 9 Stop running and transfer the gel to a filter paper, and cover it with a layer of plastic wrap. 10 Put the gel on a gel dryer and dry it at 80°C for 1 h. 11 Expose the gel to a phosphor screen for 12 h in a radiography phosphor cassette. 12 Scan the screen using a Typhoon phosphor imager.
PROTOCOL
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Step 21 are two alternative options in the protocol. At least two biological replicates are needed to obtain meaningful data in each of the options described in this protocol.
DNA damage induction and repair incubation
The quantity of excised oligomer isolated in this protocol is critical to the success of XR-seq. As the induction of DNA damage and incubation to allow repair are the most critical steps of XR-seq, we recommend performing an excision assay 26 (Box 1) to determine the ideal amount of DNA-damaging agent, the number of cells and the repair incubation time before starting the XR-seq experiment. For example, excision assay of (6-4)PP, as shown in Fig. 2a , indicates that XR-seq should be done following relatively short repair incubation times (in minutes), whereas comparable assays of CPD repair (not shown) indicate that XR-seq of these lesions should be assayed after ≥1 h of repair. For A. thaliana, yeast and E. coli, which have photolyases, until proteins are denatured and separated from excision products in Step 2D(iv), 2E(x) and 2F(viii), respectively, it is very important to use yellow light for illumination and avoid exposure to white and blue light, which can initiate reversal of the UV damage.
Cell lysis and non-chromatin fraction separation
For mammalian tissues and cells, we use lysis buffer supplemented with 0.5% (vol/vol) NP40 and an ice-cold Dounce homogenizer to gently break the cells and nuclear membranes, and, importantly, to keep the repair complex intact during the manipulation. We have observed that storing pelleted cells, mouse organs or the non-chromatin fraction at −80°C can decrease the efficiency of immunoprecipitation. We recommend performing the cell lysis and the separation of the non-chromatin fraction consecutively.
For yeast cells, we use bead beating to disrupt the cell walls and a Hirt lysis 53 procedure to separate the non-chromatin fraction. To avoid degradation of the excised oligomers by nucleases, we resuspend the cells in TE buffer with proteinase K before bead beating. For E. coli cells, we directly use the Hirt lysis procedure with 1% (wt/vol) SDS lysis buffer 19 . For A. thaliana, we first freeze the seedlings in liquid nitrogen, grind them into a powder and then resuspend them in STES buffer with phenol/ chloroform/isoamyl alcohol before vortexing with glass beads. For other species, we recommend optimizing the cell lysis approach to avoid the degradation of the excised oligomers (such as seen in Fig. 2a ) during their isolation.
Immunoprecipitation and isolation of excised oligomers
In human cells, the full-length excision products form a tight complex with TFIIH and XPG. These full-length excision products can be isolated by co-immunoprecipitation with TFIIH or XPG. For XRseq of mouse samples, precipitation with anti-TFIIH antibodies alone has been found to work best. For E. coli, A. thaliana and yeast, the co-immunoprecipitation with TFIIH or XPG is replaced with immunoprecipitation with DNA damage-specific antibodies. Precipitation of yeast or plant excision products with anti-mammalian repair proteins has not been attempted, and the E. coli excision repair proteins and reaction mechanism are completely different from those of eukaryotes. When using DNA damage-specific antibodies other than the ones we describe, we recommend analyzing the efficiency of those antibodies by radiolabeling of excised, immunoprecipitated oligomers and running them on an 11% sequencing gel as described in Box 1 ( Fig. 2a ).
Box 2 | Phenol extraction and ethanol precipitation of DNA • Timing 2 h
This procedure describes isolation of the excised oligomers. Procedure 1 Add 1 volume of phenol/chloroform/isoamyl alcohol (25:24:1) and pulse-vortex for 10 s. 2 Spin at 16,800g for 5 min at room temperature and transfer the upper layer to a new 1.5-ml tube. 3 Add 2.5 volumes of 100% (vol/vol) ethanol, 0.10 volume of 3 M NaAc (pH 5.2) and 1 µl of glycogen to the tube, mix the solution well by inverting ten times, and place the tube at −20°C for 1h. 4 Spin at 16,800g for 30 min at 4°C to pellet the DNA, and then discard the supernatant. 5 Add 190 µl of 70% ethanol to the tube, spin at 16,800g for 5 min at 4°C, and discard the supernatant.
c CRITICAL STEP It is important to avoid discarding the small DNA pellet. 6 Wash the pellet again by repeating step 5. 7 Remove the residual liquid carefully and air-dry the pellet for 3-5 min.
c CRITICAL STEP It is important to avoid over drying of the DNA pellet. 8 Dissolve the pellet with an appropriate volume of TE or nuclease-free H 2 O.
Controls
We recommend including a no-UV treatment group in Step 1. In Step 20, we strongly recommend including a negative control in which the enzyme for DNA damage reversal or TLS is omitted. After the pilot PCR, this will result in the absence of PCR product in Step 29 ( Fig. 2b) . Success of the DNA damage reversal or TLS is indicated by the presence of a PCR product of the expected size ( Fig. 2b ). 
Materials
Reagents
Reagent setup
Liquid LB medium To prepare liquid LB medium, dissolve 20 g of LB base (powder) per liter of distilled water. Autoclave the medium and store at 4°C for up to 12 months.
MS agar medium
To prepare MS agar medium, dissolve 4.33 g of MS basal medium, 20 g of sucrose and 8 g of agar per liter of distilled water, and adjust the pH to 5.7 with KOH. Autoclave and store at 4°C for up to 12 months.
YPD medium
To prepare YPD medium, dissolve 10 g of yeast extract, 20 g of peptone and 20 g of dextrose per liter of distilled water. Autoclave and store at 4°C for up to 12 months.
M Tris-HCl buffer
To prepare 1 M, pH 8.0, Tris-HCl buffer, dissolve 121.2 g of Tris base in 800 ml of distilled water, adjust the pH to 8.0 with HCl, and then add distilled water to bring the volume to 1 liter. Autoclave and store at room temperature for up to 12 months.
M EDTA stock solution
To prepare 0.5 M, pH 8.0, EDTA stock solution, add 186.12 g of EDTA to 700 ml of distilled water, adjust the pH to 8.0 with NaOH (EDTA will dissolve when the pH is adjusted to 8.0), and then add distilled water to bring the volume to 1 liter. Autoclave and store at room temperature for up to 12 months.
TE buffer TE buffer is 10 mM Tris and 1 mM EDTA, pH 8.0. To prepare the buffer, mix 10 ml of 1 M Tris-HCl (pH 8.0), and 2 ml of 0.5 M EDTA, and add sterilized distilled water to bring the volume to 1 liter. Store at room temperature for up to 12 months.
10% (wt/vol) SDS
To prepare 10% (wt/vol) SDS solution, dissolve 1 g of SDS powder in a total volume of 10 ml of distilled water. Store at room temperature for up to 12 months.
M NaCl
To prepare 5 M NaCl solution, dissolve 292 g of NaCl in a total volume of 1 liter of distilled water. Autoclave and store at room temperature for up to 12 months.
2% (wt/vol) Glucose (dextrose)
To prepare 2% (wt/vol) glucose solution, dissolve 20 g of dextrose in a total volume of 1 liter of distilled water. Filter-sterilize and store at 4°C for up to 12 months.
M NaAc
To prepare 3 M, pH 5.2, NaAc solution, dissolve 40.8 g of NaAc in 40 ml of distilled water, adjust the pH to 5.2 with HAc, and then add distilled water to bring the volume to 100 ml. Autoclave and store at room temperature for up to 12 months.
mM Cisplatin solution (in vitro)
To prepare 20 mM cisplatin solution, dissolve 6 mg of cisplatin in 1 ml of DMSO. Prepare this solution fresh before use.
mM BPDE solution
To prepare 4 mM BPDE solution, dissolve 1.2 mg of BPDE in 1 ml of DMSO. Prepare fresh solution before use.
M NaCN
To prepare 4 M NaCN solution, dissolve 196 mg of NaCN in 1 ml of buffer EB. Prepare fresh solution before use.
M HEPES buffer
To prepare 1 M, pH 7.9, HEPES buffer, dissolve 238.3 g of HEPES in 800 ml of distilled water, adjust the pH to 7.9 with NaOH, and then add distilled water to bring the volume to 1 liter. Filter-sterilize and store at 4°C for up to 12 months.
M KCl stock solution
To prepare 2 M KCl stock solution, dissolve 74.55 g of KCl in a total volume of 500 ml of distilled water. Autoclave and store at room temperature for up to 12 months.
M MgCl 2 stock solution
To prepare 1 M MgCl 2 stock solution, dissolve 20.33 g of MgCl 2 ·6H 2 O in a total volume of 100 ml of distilled water. Autoclave and store at room temperature for up to 12 months.
M DTT stock solution
To prepare 1 M DTT stock solution, dissolve 1.54 g of DTT in a total volume of 10 ml of distilled water. Filter-sterilize and store at −20°C for up to 12 months. 
30% (wt/vol) 29:1 acrylamide/bisacrylamide stock solution
To prepare 30% (wt/vol) 29:1 acrylamide/bisacrylamide stock solution, dissolve 29 g of acrylamide powder and 1 g of bisacrylamide powder in a total volume of 100 ml of distilled water. Pass the solution through a 0.22-μm filter and store at 4°C for up to 6 months (avoid light).
10% (wt/vol) APS solution
To prepare 10% (wt/vol) APS solution, dissolve 0.1 g of APS powder in a total volume of 1 ml of distilled water. Store at 4°C for up to 1 week (avoid light).
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Native polyacrylamide gel (10%) Native polyacrylamide gel (10%) is 10% (wt/vol) acrylamide/bisacrylamide 29:1, 1× TBE, 1.67% (wt/vol) APS and 0.83% (vol/vol) TEMED. To prepare two gels, mix 4 ml of 30% (wt/vol) acrylamide/ bisacrylamide solution, 5.6 ml of distilled water, 2.4 ml of 5× TBE, 200 μl of 10% (wt/vol) APS and 10 μl of TEMED. Prepare fresh gels before use.
Denaturing gel (10%) working solution Denaturing gel (10%) working solution is 10% (wt/vol) acrylamide/bisacrylamide 19:1, 2× TBE and 7 M urea. Dissolve 47.5 g of acrylamide powder, 2.5 g of bisacrylamide powder and 210.2 g of urea in 200 ml of 5× TBE stock, then add distilled water to a total volume of 500 ml. Heat the mixture to dissolve the powders (do not exceed 30°C during dissolving). Pass the solution through a 0.22-μm filter and store at room temperature for up to 6 months (avoid light). To prepare the gel, add 200 μl of 10% (wt/vol) APS and 10 μl of TEMED to 40 ml of this solution immediately before use.
Gel-loading dye for denaturing gel Gel-loading dye for denaturing gel is 95% (vol/vol) deionized formamide, 0.025% (wt/vol) bromophenol blue, 0.025% (wt/vol) xylene cyanol FF and 5 mM EDTA. To prepare the gel, mix 9.5 ml of formamide, 2.5 mg of bromophenol blue, 2.5 mg of xylene cyanol FF, 100 µl of 0.5 M EDTA (pH 8.0) and 400 µl of distilled water. Store in aliquots at −20°C for up to 12 months.
Elution buffer I (for immunoprecipitation)
Elution buffer I is 10 mM Tris-HCl, 1 mM EDTA and 1% (wt/vol) SDS, pH 8.0. To prepare the buffer, mix 1 ml of 1 M Tris-HCl (pH 8.0), 10 ml of 10% (wt/vol) SDS and 0.2 ml of 0.5 M EDTA, and then add sterilized distilled water to bring the volume to 100 ml. Store at room temperature for up to 12 months.
10× Hybridization buffer 10× Hybridization buffer is 100 mM Tris-HCl, 1 M NaCl and 1 mM EDTA, pH 8.0. To prepare the buffer, mix 1 ml of 1 M Tris-HCl (pH 8.0), 2 ml of 5 M NaCl and 20 μl of 0.5 M EDTA, and then add sterilized distilled water to bring the volume to 10 ml. Store at room temperature for up to 12 months.
10% (wt/vol) Sodium deoxycholate
To prepare 10% (wt/vol) sodium deoxycholate solution, dissolve 1 g of sodium deoxycholate powder in a total volume of 10 ml of distilled water. Store at room temperature for up to 12 months.
Reaction buffer
Reaction buffer is 20 mM Tris-HCl, 2 mM EDTA, 150 mM NaCl, 1% (vol/vol) Triton X-100 and 0.5% (wt/vol) sodium deoxycholate, pH 8.0. To prepare the buffer, mix 1 ml of 1 M Tris-HCl (pH 8.0), 1.5 ml of 5 M NaCl, 0.2 ml of 0.5 M EDTA, 0.5 ml of Triton X-100 and 2.5 ml of 10% (wt/vol) sodium deoxycholate, and then add sterilized distilled water to bring the volume to 50 ml. Store at room temperature for up to 12 months.
5× Reaction buffer 5× Reaction buffer is 100 mM Tris-HCl, 10 mM EDTA, 750 mM NaCl, 5% (vol/vol) Triton X-100 and 2.5% (wt/vol) sodium deoxycholate, pH 8.0. To prepare the buffer, mix 1 ml of 1 M Tris-HCl (pH 8.0), 1.5 ml of 5 M NaCl, 0.2 ml of 0.5 M EDTA, 0.5 ml of Triton X-100 and 2.5 ml of 10% (wt/vol) sodium deoxycholate, and then add sterilized distilled water to bring the volume to 10 ml. Store at room temperature for up to 12 months.
Wash buffer I
Wash buffer I is 20 mM Tris-HCl, 2 mM EDTA, 150 mM NaCl, 1% (vol/vol) TritonX-100 and 0.1% (wt/vol) SDS, pH 8.0. To prepare the buffer, mix 1 ml of 1 M Tris-HCl (pH 8.0), 1.5 ml of 5 M NaCl, 0.2 ml of 0.5 M EDTA, 0.5 ml of Triton X-100 and 0.5 ml of 10% (wt/vol) SDS, and then add sterilized distilled water to bring the volume to 50 ml. Store at room temperature for up to 12 months.
Wash buffer II
Wash buffer II is 20 mM Tris-HCl, 2 mM EDTA, 500 mM NaCl, 1% (vol/vol) TritonX-100 and 0.1% (wt/vol) SDS, pH 8.0. To prepare the buffer, mix 1 ml of 1 M Tris-HCl (pH 8.0), 5 ml of 5 M NaCl, 0.2 ml of 0.5 M EDTA, 0.5 ml of Triton X-100 and 0.5 ml of 10% (wt/vol) SDS, and then add sterilized distilled water to bring the volume to 50 ml. Store at room temperature for up to 12 months.
M LiCl stock solution
To prepare 5 M LiCl stock solution, dissolve 42.39 g of LiCl in a total volume of 200 ml of distilled water. Autoclave and store at room temperature for up to 12 months. PEX buffer PEX buffer is 1× PBS, 2 mM EDTA and 0.1% (vol/vol) Triton X-100. To prepare the buffer, mix 5 ml of 10× PBS, 0.2 ml of 0.5 M EDTA and 50 μl of Triton X-100, and then add sterilized distilled water to bring the volume to 50 ml. Store at room temperature for up to 12 months.
Wash buffer III
1× PEXB buffer 1× PEXB buffer is 1× PBS, 2 mM EDTA, 0.1% (vol/vol) Triton X-100 and 0.025% (wt/vol) BSA. To prepare the buffer, mix 5 ml of 10× PBS, 0.2 ml of 0.5 M EDTA, 50 μl of Triton X-100 and 0.625 ml of 20 mg/ml BSA, and then add sterilized distilled water to bring the volume to 50 ml. Store at 4°C for up to 6 months.
5× PEXB buffer 5× PEXB buffer is 5× PBS, 10 mM EDTA, 0.5% (vol/vol) Triton X-100 and 0.125% (wt/vol) BSA. To prepare the buffer, mix 5 ml of 10× PBS, 0.2 ml of 0.5 M EDTA, 50 μl of Triton X-100 and 0.625 ml of 20 mg/ml BSA, and then add sterilized distilled water to bring the volume to10 ml. Store at 4°C for up to 6 months.
10× Photoreactivation buffer 10× Photoreactivation buffer is 500 mM Tris-HCl, 1,000 mM NaCl, 10 mM EDTA and 100 mM DTT, pH 8.0. To prepare the buffer, mix 0.5 ml of 1 M Tris-HCl (pH 8.0), 0.2 ml of 5 M NaCl, 20 μl of 0.5 M EDTA and 0.1 ml of 1 M DTT, and then add sterilized distilled water to bring the volume to 1 ml. Store at −20°C for up to 12 months.
M Potassium phosphate buffer
To prepare 1 M potassium phosphate buffer (pH 7.0), dissolve 1.07 g of K 2 HPO 4 and 0.524 g of KH 2 PO 4 in a total volume of 10 ml of distilled water. Autoclave and store at room temperature for up to 12 months. Elution buffer II (for recovering DNA from polyacrylamide gel) Elution buffer II is 10 mM Tris, 300 mM NaCl and 1 mM EDTA, pH 8.0. To prepare the buffer, mix 1 ml of 1 M Tris-HCl (pH 8.0), 6 ml of 5 M NaCl and 0.2 ml of 0.5 M EDTA, and then add sterilized distilled water to bring the volume to 100 ml. Store at room temperature for up to 12 months.
A3 and A5 adapters
To prepare the adapters, combine 20 μl of A3F or A5F (250 μM) with 20 μl of A3R or A5R (250 μM), respectively (the oligonucleotides are listed in Table 1 ); add 5 μl of 10× hybridization buffer and 5 μl of nuclease-free H 2 O; and mix well by pipetting up and down five times. Boil for 1 min in water, then turn off the heater and let the solution naturally cool to 25°C to obtain 100 μM A3 or A5 stock solution. Combine 10 μl of A3 or A5 stock solution (100 μM) with 4 μl of 10× hybridization buffer and 36 μl of nuclease-free H 2 O, and then mix well by pipetting up and down five times to obtain 20 μM A3 or A5 working solutions. Store the stock solutions and working solutions at −20°C for up to 24 months (stock solutions) or 12 months (working solutions).
Equipment setup
Bioinformatics pipeline
The pipeline is run in a Linux environment. We provide a documented script library to help users to set up an environment and install the necessary prerequisites (https://github.com/adebali/ NGStoolkit). The sequence processing steps (Steps 47-52) are collected in a single .bash script, which can be found at https://github.com/adebali/NGStoolkit/blob/master/stable/XR-seq-basics.sh. To bypass the dependency installation process (e.g., Cutadapt, Bowtie2, SAMtools, BEDTools), we provide a Docker image (see the repository) that provides a Linux container containing all the necessary programs and scripts needed to perform the basic analysis provided here. See the documentation on the repository home page for setup instructions. (F) Treatment of yeast S. cerevisiae with UV c CRITICAL In the following steps, the volume of yeast culture for each time point used in this protocol depends on the yeast strain genotype, growth conditions (growth medium, temperature and phase), UV dose and the duration of repair incubation. The total culture volume should be calculated according to the specific experimental design. Here, we describe the protocol for the yeast Y452 strain cultured in YPD medium at 30°C with shaking. c CRITICAL In the following procedure, the volume of E. coli culture needed for each time point depends on the E. coli strain genotype, growth conditions (growth medium, temperature and phase), UV dose and the duration of repair incubation.~300 ml of log-phase wild-type, phr − (photolyase deficient mutant) or other mutant cells is needed for one XR-seq experiment, although for uvrD − cells, 30 ml is sufficient. Here, we describe the protocol for the STL4150 strain (Biological materials) cultured in LB medium at 37°C with shaking. (i) Inoculate 320 ml of LB medium with a 1:15 to 1:50 dilution of overnight culture of the strain, grow at 37°C with shaking (160 r.p.m.) until the OD 600 value reaches 0.3-0.8 to achieve mid-log phase (1-3 h), or to an OD 600 value dictated by experimental needs. (ii) Transfer 15 ml of E. coli cells to a 150-mm tissue culture dish, place the dish with the cover off under a GE germicidal lamp emitting primarily 254-nm UV light (2 J/m 2 /s) for 60 s. Shake the cells gently during the UV irradiation process. A wire attached to a dish beneath the sample allows the cells to be shaken remotely, avoiding exposure of the investigator to UV. ! CAUTION UV irradiation is harmful and carcinogenic. Handle the lamp in a hood and wear protective clothing, gloves and safety goggles. c CRITICAL STEP To prevent photoreactivation, either use phr − cells or handle UV-irradiated cells under yellow light. (iii) Incubate the irradiated cells at room temperature or 37°C for an appropriate repair time period according to the specific experiment. Then place the cells on ice. Repeat irradiation and repair 20 times to accumulate 300 ml of irradiated, repaired cells. Then proceed directly to cell lysis and fractionation (Step 2). c CRITICAL STEP Irradiation and repair of 20 plates takes time. The OD 600 value of the culture started in Step 1G(i) may change substantially during irradiation and repair. If it is important that the OD 600 value at the time of irradiation be fixed, then the irradiation and repair of plates of cells can be done in multiple smaller batches (e.g., five plates per batch or ten plates per batch) at different times so that the cells can be irradiated at a given OD 600 value. In this case, each batch will require a separate culture in Step 1G(i). Delayed inoculation of these separate cultures will provide cultures at the appropriate OD 600 value at delayed times.
Cell lysis and non-chromatin fraction separation • Timing 1 h plus overnight and~6 h the next day
2 Lyse cells treated with UV, cisplatin or BPDE and separate the non-chromatin fraction containing the excised oligomers. Perform this step by choosing one of the options (A-F) based on the organism and DNA-damaging agent that are used. c CRITICAL Before performing one of the following procedures, we recommend performing an optional excision assay as described in Box 1 to validate the successful isolation of the excision products. By visualizing and estimating the amount of excision products, this excision assay will be useful for determining the optimal parameters in XR-seq, such as the amount of DNA-damaging agent, the total number of cells and the duration of repair incubation. The total number of organs should be optimized according to the experimental design. For example, sufficient excised oligomers for XR-seq can be obtained from one liver, whereas it generally requires 4-6 kidneys. In this procedure, we use one mouse to perform XRseq in liver. (i) Sacrifice the mouse by CO 2 exposure for 5 min, harvest the liver, and immediately wash it two times with 30 ml ice-cold 1× PBS in a 50-ml tube. c CAUTION Euthanasia should be carried out according to your institution's approved protocol.
(ii) Transfer the liver to a 10-ml Dounce homogenizer, add 5 ml of ice-cold 1× PBS, and homogenize using 15 strokes on ice. c CRITICAL STEP Be sure to use the loose (type A) pestle and keep the homogenizer in the ice while doing the strokes. (iii) Transfer the homogenized organ to a 50-ml tube, spin at 3,000g for 4 min at 4°C, and discard the supernatant.
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(iv) Wash the homogenized organ: resuspend the pellet in 30 ml of ice-cold 1× PBS, spin at 3,000g for 4 min at 4°C, and discard the supernatant. Repeat the wash two times to remove fat. (v) Resuspend the pellet in 5 ml of ice-cold buffer A and incubate on ice for 10 min. (vi) Transfer the cell suspension to a 15-ml ice-cold Dounce homogenizer and disrupt the cells using 60 strokes of a tight (type B) pestle. c CRITICAL STEP Be sure to use the tight pestle and keep the homogenizer in the ice while doing the strokes. (vii) Split the 5 ml of lysed cells into four 1.25-ml aliquots, transfer each aliquot to a 1.5-ml tube and pellet the chromatin fraction by centrifugation at 16,800g for 30 min at 4°C. Step 3C(vi) or 3D(iii) and incubate in a digital heating, shaking dry bath at 1,000 r.p.m. for 10 min at 65°C. (ii) Spin the tube at 2,000g for 2 s at room temperature and place it on a magnetic rack.
Transfer the elution solution to a new 1.5-ml tube when it becomes clear. 
h
This procedure describes how to pre-incubate the Dynabeads with anti-CPD, anti-(6-4)PP and anti-BPDE antibodies for one reaction. Procedure c CRITICAL Calculate the total amount of beads and antibodies needed according to the experiment and prepare a mix for all the samples. Keep samples and buffers on ice, except when using the magnetic stand at room temperature.
1 Transfer 5 µl of Protein G Dynabeads and 5 µl of anti-rabbit Dynabeads per immunoprecipitation reaction to a new 1.5-ml tube, place the tube on a magnetic rack for 2 min, and then discard the original Dynabeads buffer. c CRITICAL STEP The Dynabeads should be resuspended before use. They should be shaken during incubations to avoid settling. We generally prepare at least five immunoprecipitation reactions at a time. 2 Remove the tube from the magnetic rack. Resuspend the Dynabeads in 200 µl of reaction buffer, place the tube on a magnetic rack for 2 min, and discard the supernatant to wash the beads. Immunoprecipitation with DNA damage-specific antibodies (second round) • Timing 6 h plus overnight and~6 h the next day 10 Transfer the 20 µl of ligation mixture from Step 9 to a new 1.5-ml tube, add 80 µl of nuclease-free H 2 O to the tube, and mix well by pulse-vortexing. 11 Extract the ligation product, following the protocol described in Box 2, and dissolve the pellet in 80 µl of nuclease-free H 2 O. 12 Boil the tube containing the ligation product in a water bath for 1 min, place it into ice water immediately, spin the tube at 2,000g for 2 s at room temperature and then add 1 µl of salmon sperm DNA (10 µg/µl) to the tube. 
This procedure describes how to pre-incubate the Dynabeads with anti-cisplatin antibody. Procedure 1 Transfer 25 µl of anti-rat Dynabeads per immunoprecipitation reaction to a new 1.5-ml tube, place the tube on a magnetic rack for 2 min, and then discard the original Dynabeads buffer. c CRITICAL STEP It is important to resuspend the Dynabeads by pulse-vortexing before use. We generally prepare at least five immunoprecipitation reactions at a time. 2 Remove the tube from the magnetic rack. Resuspend the Dynabeads in 200 µl of 1× PEXB buffer, place the tube on a magnetic rack for 2 min, and discard the supernatant to wash the beads. 3 Repeat step 2 to wash the Dynabeads two times. 4 Resuspend the Dynabeads in 50 µl of 1× PEXB buffer, which is two times the original volume of Dynabeads. 5 Add 1 µl of anti-cisplatin antibody to the Dynabeads suspension. 6 Place the tube on a rotator and incubate the reaction for 2 h at 4°C. 7 Place the tube on a magnetic rack for 2 min, and then discard the supernatant. 27 Add 2 µl of 6× gel-loading dye (with SDS) to each sample and mix it well. 28 Load 6 µl of the mixture from each sample and 2 µl of low-molecular-weight DNA ladder to the wells of a 10% native polyacrylamide gel, and run the gel in 1× TBE buffer at 125 V for 1.5 h. 29 Stain the gel with 20 ml of SYBR gold (1:10,000 dilution) solution on a rocker for 5 min, visualize it using the ChemiDoc XRS + Imaging System, and estimate the appropriate number of PCR cycles for the following XR-seq library construction (Fig. 2b) . c CRITICAL STEP It is important that the final PCR product be~50 ng and the number of PCR cycles be ≤15. After choosing the optimal number of PCR cycles from the gel image of the pilot PCR reaction, users should estimate the number of PCR cycles needed for library preparation (Step 30). We calculate the optimal number of PCR cycles as follows: we use only 1/100 of the DNA template in the pilot PCR reaction and 100× more DNA template in the library preparation PCR reaction; in each PCR cycle, the PCR products will double; thus, after 6 PCR cycles, the final PCR products will increase 64-fold (we approximate this to 100-fold). We subtract 6 from the optimal number of cycles in the pilot PCR to account for using 100 times more template in the library PCR reaction to obtain the correct number of PCR cycles to use in Step 30. ? TROUBLESHOOTING 30 Prepare the PCR mix as shown below and divide it into aliquots (20 µl per reaction). Add the remaining 10 µl of the products from Step 21 to each aliquot, and then mix well by pipetting up and down at least ten times. 35 Stain the gel with 20 ml of SYBR gold solution (1:10,000 dilution) on a rocker for 5 min, acquire the image using the ChemiDoc XRS + Imaging System, and print it out in its original size. 36 Sandwich the gel in between the two parts of a sheet protector, place the sandwiched sheet protector on top of the gel image, and make sure that the gel completely overlaps the gel image. 37 Use a blade to cut out the band that contains the correct PCR product, cut the excised band into six pieces on the sheet protector, and then transfer the pieces to a new Gel Breaker tube. 38 Insert the Gel Breaker tube into a new 1.5-ml tube and centrifuge at 16,800g for 2 min at room temperature. 39 Add 200 µl of elution buffer II to the gel fragments and elute the DNA by incubating the sample in a digital heating, shaking dry bath at 1,000 r.p.m. for at least 3 h at 40°C. 40 Transfer the eluate to a 1.5-ml tube, add 100 µl of elution buffer II, and then continue the elution in a digital heating, shaking dry bath at 1,000 r.p.m. for at least 3 h at 40°C. 41 Combine the second eluate with the first one, transfer the 300 µl of eluate to a Spin-X centrifuge tube filter stacked on a new 1.5-ml tube, and then centrifuge at 580g for 2 min at room temperature. c CRITICAL STEP Store the tubes containing the small gel pieces at 4°C for additional elution if the elution efficiency is low. 42 Discard the Spin-X centrifuge tube filter, extract the XR-seq library as described in Box 2, and dissolve the pellet with 10 µl of buffer EB. 
Bioinformatics analysis • Timing 2-24 h
c CRITICAL The pipeline is run in a Linux environment. We provide a documented script library for users that sets up the environment and installs the necessary prerequisites (https://github.com/adebali/ NGStoolkit). The sequence processing steps (Steps 47-60) are collected in a single .bash script, which can be found at https://github.com/adebali/NGStoolkit/blob/master/stable/XR-seq-basics.sh. To bypass the dependency installation process (e.g., Cutadapt, Bowtie2, SAMtools, BEDTools), we provide a Docker image (see the repository), which provides a Linux container containing all the programs and scripts needed to perform the basic analysis provided here. See the documentation for setup instructions on the repository home page. 47 CRITICAL STEP If the total genome coverage is low (<1×), the likelihood of retrieving the same excised oligomer multiple times would be low as well. The identical oligomers are more likely to be the products of PCR amplification. The same excised oligomer can be represented more than one time as a result of PCR artifacts. Therefore, we remove such artifacts by keeping one of the duplicated reads (regions) in the .bed file. If the genome size is low (e.g., E. coli), the genome coverage will be high, and therefore the deduplication process would remove the real duplicated excised products. In that case, the -u option can be deleted to sort the .bed file without deduplication. A sorted .bed file is necessary for efficient further processing. 52 To analyze the data, carry out the following steps. First, count total mapped reads as follows: CRITICAL STEP Read length distribution usually yields one or multiple major populations between 10 and 32 nt. The remaining minor read lengths (e.g., ≥50 nt) are considered unspecific reads rather than excised oligomers. If the unspecific read length ratio is high (>1%) and cannot be ignored, the reads should be filtered to include only the ones between 10 and 32 nt. The command below can be used for filtering. where n is the read count, 1 is the length of the gene and m is the total number of mapped reads. Note that repair in genic regions provides only a subset of the entire map. For advanced analyses of the entire genome, ${SAMPLE}_cutadapt_sorted.bed should be used as the starting file.
Troubleshooting
Troubleshooting advice can be found in Table 2 . Step 39 with overnight incubation 45 Extra peak at the~118-bp position PCR products of adapter dimers are cut off in Step 37 Precisely cut off the band corresponding to the XR-seq library only. See example in Fig. 2d Anticipated results XR-seq libraries constructed by following this protocol typically have a total yield of 5-100 ng. For mammalian cells, gel electrophoresis of a typical XR-seq library after the final PCR amplification shows a major band at the 145-nt position (Fig. 2b,c,e ). The length distributions of the excised oligomers from CPD XR-seq and CPD tXR-seq show the same pattern (Fig. 2f ). The sizes of major PCR products for E. coli, yeast and A. thaliana cells are 130, 142 and 146 nt, respectively. High-throughput sequencing of a CPD XR-seq library 14 (SRA ID: SRX997094) from human NHF1 cells typically has the features described below. The pipeline starts with~20 million reads. Repair asymmetry between strands that is due to transcription-coupled repair in the expressed genes is observed. The transcribed strands are the plus (above) and minus (below) strands for ZBTB4 and POLR2A, respectively. Therefore, those regions are repaired at higher levels because of transcription-coupled repair. The magnitude of the asymmetry varies depending on organism, gene and damage type. Data in c are from Hu et al. 13 . Histograms were plotted using the R software and the ggplot2 64 package, and the genomic region-specific repair levels were captured using IGV 65 .
~16 million of the reads (81%) can be mapped to the genome with the quality score criterion (>20) applied. The deduplication process results in~10 million reads corresponding to 52% of the starting read number. 99.95% of the deduplicated reads are ≤32 nt (Fig. 3a) . The damage site nucleotides (dipyrimidines for UV damage) are expected to be enriched at 5-6 nt away from the 3ʹ end of the excised oligomers (Fig. 3b ). For well-established transcription-coupled excision repair events in which only one strand is actively transcribed during the repair process, repair asymmetry between the two strands should be observed for expressed genes (Fig. 3c ). Because the antisense (noncoding) strand is transcribed by RNAP II, it is expected to have higher levels of repair than the opposite sense (coding) strand (Fig. 3c ). 
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Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists may be useful.
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